We offer fully automated chromatography systems with customized softwares, providing customers ample time to manage R&D while the samples are being processed and results decoded
Dr. Jain brings extensive experience in the biotech and pharma sectors and has been instrumental in driving innovation, vaccine development, and healthcare advancement
We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms
Shilpa will deliver end-to-end services including CMC development, process scale-up, GMP clinical supply, and commercial manufacturing support
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
The private funding rose 38% amid growing international collaborations and CDMO demand
Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies
The capacity addition to be implemented in a phased manner amid evolving business and market dynamics
The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
